A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum.
Plasmodium falciparum merozoite surface protein 3 is a malaria vaccine candidate that was identified, characterised, and developed based on a unique immuno-clinical approach. The vaccine construct was derived from regions fully conserved among various strains and containing B cell epitopes targeted...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2005-11-01
|
| Series: | PLoS Medicine |
| Online Access: | http://europepmc.org/articles/PMC1277929?pdf=render |